Literature DB >> 19332076

Fuel specificity of the hepatitis C virus NS3 helicase.

Craig A Belon1, David N Frick.   

Abstract

The hepatitis C virus (HCV) NS3 protein is a helicase capable of unwinding duplex RNA or DNA. This study uses a newly developed molecular-beacon-based helicase assay (MBHA) to investigate how nucleoside triphosphates (NTPs) fuel HCV helicase-catalyzed DNA unwinding. The MBHA monitors the irreversible helicase-catalyzed displacement of an oligonucleotide-bound molecular beacon so that rates of helicase translocation can be directly measured in real time. The MBHA reveals that HCV helicase unwinds DNA at different rates depending on the nature and concentration of NTPs in solution, such that the fastest reactions are observed in the presence of CTP followed by ATP, UTP, and GTP. 3'-Deoxy-NTPs generally support faster DNA unwinding, with dTTP supporting faster rates than any other canonical (d)NTP. The presence of an intact NS3 protease domain makes HCV helicase somewhat less specific than truncated NS3 bearing only its helicase region (NS3h). Various NTPs bind NS3h with similar affinities, but each NTP supports a different unwinding rate and processivity. Studies with NTP analogs reveal that specificity is determined by the nature of the Watson-Crick base-pairing region of the NTP base and the nature of the functional groups attached to the 2' and 3' carbons of the NTP sugar. The divalent metal bridging the NTP to NS3h also influences observed unwinding rates, with Mn(2+) supporting about 10 times faster unwinding than Mg(2+). Unlike Mg(2+), Mn(2+) does not support HCV helicase-catalyzed ATP hydrolysis in the absence of stimulating nucleic acids. Results are discussed in relation to models for how ATP might fuel the unwinding reaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332076      PMCID: PMC2692962          DOI: 10.1016/j.jmb.2009.03.059

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  49 in total

1.  Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA.

Authors:  H S Cho; N C Ha; L W Kang; K M Chung; S H Back; S K Jang; B H Oh
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

Review 2.  The structural and mechanochemical cycle of kinesin.

Authors:  E Mandelkow; K A Johnson
Journal:  Trends Biochem Sci       Date:  1998-11       Impact factor: 13.807

3.  Structure of the hepatitis C virus RNA helicase domain.

Authors:  N Yao; T Hesson; M Cable; Z Hong; A D Kwong; H V Le; P C Weber
Journal:  Nat Struct Biol       Date:  1997-06

4.  Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.

Authors:  A D Wardell; W Errington; G Ciaramella; J Merson; M J McGarvey
Journal:  J Gen Virol       Date:  1999-03       Impact factor: 3.891

5.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

6.  A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase.

Authors:  Mikhail K Levin; Madhura Gurjar; Smita S Patel
Journal:  Nat Struct Mol Biol       Date:  2005-04-03       Impact factor: 15.369

7.  Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing.

Authors:  Jinhua Wu; Aloke Kumar Bera; Richard J Kuhn; Janet L Smith
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.

Authors:  J L Kim; K A Morgenstern; J P Griffith; M D Dwyer; J A Thomson; M A Murcko; C Lin; P R Caron
Journal:  Structure       Date:  1998-01-15       Impact factor: 5.006

9.  Quantitative analysis of the hepatitis C virus replication complex.

Authors:  Doris Quinkert; Ralf Bartenschlager; Volker Lohmann
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

10.  Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.

Authors:  D J Porter; S A Short; M H Hanlon; F Preugschat; J E Wilson; D H Willard; T G Consler
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  12 in total

1.  Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline.

Authors:  Kelin Li; Kevin J Frankowski; Craig A Belon; Ben Neuenswander; Jean Ndjomou; Alicia M Hanson; Matthew A Shanahan; Frank J Schoenen; Brian S J Blagg; Jeffrey Aubé; David N Frick
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

2.  The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.

Authors:  Cihan Aydin; Sourav Mukherjee; Alicia M Hanson; David N Frick; Celia A Schiffer
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

3.  Molecular basis for recognition of nucleoside triphosphate by gene 4 helicase of bacteriophage T7.

Authors:  Seung-Joo Lee; Charles C Richardson
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

4.  Quantitative microspectroscopic imaging reveals viral and cellular RNA helicase interactions in live cells.

Authors:  M J Corby; Michael R Stoneman; Gabriel Biener; Joel D Paprocki; Rajesh Kolli; Valerica Raicu; David N Frick
Journal:  J Biol Chem       Date:  2017-05-08       Impact factor: 5.157

5.  Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase.

Authors:  Alicia M Hanson; John J Hernandez; William R Shadrick; David N Frick
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

6.  Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.

Authors:  Simon Despins; Moheshwarnath Issur; Isabelle Bougie; Martin Bisaillon
Journal:  Nucleic Acids Res       Date:  2010-04-25       Impact factor: 16.971

7.  UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication.

Authors:  Dawn N Ward; Daniel C Talley; Mrinalini Tavag; Samrawit Menji; Paul Schaughency; Andrea Baier; Paul J Smith
Journal:  Bioorg Med Chem Lett       Date:  2013-12-09       Impact factor: 2.823

8.  Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.

Authors:  Craig A Belon; Yoji D High; Tse-I Lin; Frederik Pauwels; David N Frick
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

9.  Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase.

Authors:  Leopoldo G Gebhard; Sergio B Kaufman; Andrea V Gamarnik
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

10.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.

Authors:  Sourav Mukherjee; Alicia M Hanson; William R Shadrick; Jean Ndjomou; Noreena L Sweeney; John J Hernandez; Diana Bartczak; Kelin Li; Kevin J Frankowski; Julie A Heck; Leggy A Arnold; Frank J Schoenen; David N Frick
Journal:  Nucleic Acids Res       Date:  2012-06-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.